THE INSTITUTE OF MEDICAL SCIENCE, THE UNIVERSITY OF TOKYO IMAGE: THE RESEARCH TEAM IDENTIFIED A GLS1 INHIBITOR THAT SELECTIVELY REMOVES SENESCENT CELLS, FOUND THAT ADMINISTRATION OF THE GLS1 INHIBITOR IMPROVES AGE-RELATED TISSUE DYSFUNCTION AND THE SYMPTOMS OF OBESE DIABETES, ARTERIOSCLEROSIS,AND NASH CREDIT: ©NAKANISHI MAKOTO, THE INSTITUTE OF MEDICAL SCIENCE, THE UNIVERSITY OF TOKYO(IMSUT) Senescent cells...
